|
1
|
Heare T, Hensley MA and Dell'orfano S:
Bone tumors: Osteosarcoma and Ewing's sarcoma. Curr Opin Pediatr.
21:365–372. 2009.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Mirabello L, Troisi RJ and Savage SA:
International osteosarcoma incidence patterns in children and
adolescents, middle ages and elderly persons. Int J Cancer.
125:229–234. 2009.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Eppert K, Wunder JS, Aneliunas V, Kandel R
and Andrulis IL: von Willebrand factor expression in osteosarcoma
metastasis. Mod Pathol. 18:388–397. 2005.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Laverdiere C, Hoang BH, Yang R, Sowers R,
Qin J, Meyers PA, Huvos AG, Healey JH and Gorlick R: Messenger RNA
expression levels of CXCR4 correlate with metastatic behavior and
outcome in patients with osteosarcoma. Clin Cancer Res.
11:2561–2567. 2005.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Urakawa H, Nishida Y, Nakashima H,
Shimoyama Y, Nakamura S and Ishiguro N: Prognostic value of
indoleamine 2,3-dioxygenase expression in high grade osteosarcoma.
Clin Exp Metastasis. 26:1005–1012. 2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bacci G, Ferrari S, Tienghi A, Bertoni F,
Mercuri M, Longhi A, Fiorentini G, Forni C, Bacchini P, Rimondini
S, De Giorgi U and Picci P: A comparison of methods of
loco-regional chemotherapy combined with systemic chemotherapy as
neo-adjuvant treatment of osteosarcoma of the extremity. Eur J Surg
Oncol. 27:98–104. 2001.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Tan ML, Choong PF and Dass CR:
Osteosarcoma: Conventional treatment vs. gene therapy. Cancer Biol
Ther. 8:106–117. 2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lang F, Busch GL, Ritter M, Völkl H,
Waldegger S, Gulbins E and Häussinger D: Functional significance of
cell volume regulatory mechanisms. Physiol Rev. 78:247–306.
1998.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Pedersen SF, Hoffmann EK and Novak I: Cell
volume regulation in epithelial physiology and cancer. Front
Physiol. 4(233)2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Pedersen SF, Klausen TK and Nilius B: The
identification of a volume-regulated anion channel: An amazing
Odyssey. Acta Physiol (Oxf). 213:868–881. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Syeda R, Qiu Z, Dubin AE, Murthy SE,
Florendo MN, Mason DE, Mathur J, Cahalan SM, Peters EC, Montal M
and Patapoutian A: LRRC8 proteins form volume-regulated anion
channels that sense ionic strength. Cell. 164:499–511.
2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Trothe J, Ritzmann D, Lang V, Scholz P,
Pul Ü, Kaufmann R, Buerger C and Ertongur-Fauth T: Hypotonic stress
response of human keratinocytes involves LRRC8A as component of
volume-regulated anion channels. Exp Dermatol. 27:1352–1360.
2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Pedersen SF, Okada Y and Nilius B:
Biophysics and physiology of the volume-regulated anion channel
(VRAC)/Volume-sensitive outwardly rectifying anion channel (VSOR).
Pflugers Arch. 468:371–383. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kunzelmann K: Ion channels in regulated
cell death. Cell Mol Life Sci. 73:2387–2403. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Xu B, Jin X, Min L, Li Q, Deng L, Wu H,
Lin G, Chen L, Zhang H, Li C, et al: Chloride channel-3 promotes
tumor metastasis by regulating membrane ruffling and is associated
with poor survival. Oncotarget. 6:2434–2450. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Sawada A, Takihara Y, Kim JY,
Matsuda-Hashii Y, Tokimasa S, Fujisaki H, Kubota K, Endo H, Onodera
T, Ohta H, et al: A congenital mutation of the novel gene LRRC8
causes agammaglobulinemia in humans. J Clin Invest. 112:1707–1713.
2003.PubMed/NCBI View
Article : Google Scholar
|
|
17
|
Choi H, Ettinger N, Rohrbough J, Dikalova
A, Nguyen HN and Lamb FS: LRRC8A channels support TNFα-induced
superoxide production by Nox1 which is required for receptor
endocytosis. Free Radic Biol Med. 101:413–423. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Rubino S, Bach MD, Schober AL, Lambert IH
and Mongin AA: Downregulation of leucine-rich repeat-containing 8A
limits proliferation and increases sensitivity of glioblastoma to
temozolomide and carmustine. Front Oncol. 8(142)2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhang H, Deng Z, Zhang D, Li H, Zhang L,
Niu J, Zuo W, Fu R, Fan L, Ye JH and She J: High expression of
leucinerich repeatcontaining 8A is indicative of a worse outcome of
colon cancer patients by enhancing cancer cell growth and
metastasis. Oncol Rep. 40:1275–1286. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Sorensen BH, Nielsen D, Thorsteinsdottir
UA, Hoffmann EK and Lambert IH: Downregulation of LRRC8A protects
human ovarian and alveolar carcinoma cells against
cisplatin-induced expression of p53, MDM2, p21Waf1/Cip1, and
caspase-9/-3 activation. Am J Physiol Cell Physioly. 310:C857–C873.
2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Sorensen BH, Dam CS, Sturup S and Lambert
IH: Dual role of LRRC8A-containing transporters on cisplatin
resistance in human ovarian cancer cells. J Inorg Biochem.
160:287–295. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Liu C, Zhang Y, Zhang K, Bian C, Zhao Y
and Zhang J: Expression of estrogen receptors, androgen receptor
and steroid receptor coactivator-3 is negatively correlated to the
differentiation of astrocytic tumors. Cancer Epidemiol. 38:291–297.
2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the Surveillance, Epidemiology, and End Results Program.
Cancer. 115:1531–1543. 2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Karpik M and Reszeć J: Low grade
chondrosarcoma-epidemiology, diagnosis, treatment. Ortop Traumatol
Rehabil. 20:65–70. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Estrada-Villaseñor EG, Flores-Carmona JF,
Delgado-Cedillo EA and Rico-Martínez G: Bone tumor frequency in
adults and elderly. Acta Ortop Mex. 22:356–360. 2008.PubMed/NCBI(In Spanish).
|
|
27
|
Konishi T, Shiozaki A, Kosuga T, Kudou M,
Shoda K, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, et
al: LRRC8A expression influences growth of esophageal squamous cell
carcinoma. Am J Pathol. 189:1973–1985. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Lu J, Xu F and Zhang J: Inhibition of
angiotensin II-induced cerebrovascular smooth muscle cell
proliferation by LRRC8A downregulation through suppressing PI3K/AKT
activation. Hum Cell. 32:316–325. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Platt CD, Chou J, Houlihan P, Badran YR,
Kumar L, Bainter W, Poliani PL, Perez CJ, Dent SYR, Clapham DE, et
al: Leucine-rich repeat containing 8A.
|
|
30
|
LRRC8A)-dependent volume-regulated anion
channel activity is dispensable for T-cell development and
function. J Allergy Clin Immunol. 140:1651–1659.e1. 2017.PubMed/NCBI View Article : Google Scholar
|
